Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients-Reference-Cited by-同舟云学术

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients

Published:2001 Issue:3 Volume:47 Page:205-211
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Berruti Alfredo,Dogliotti Luigi,Mosca Alessandra,Tarabuzzi Roberto,Torta Mirella,Mari Mauro,Gorzegno Gabriella,Fontana Dario,Angeli Alberto

Publisher

Wiley

Subject

Urology,Oncology

Reference41 articles.

1. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors

2. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer

3. Neuroendocrine differentiation in prostatic malignancy

4. Neuroendocrine differentiation in prostatic carcinoma: An update

5. Neuroendocrine differentiation in prostatic carcinoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Combined Effect of Downregulated RB1 and Overexpressed lncRNA SSTRS-AS1 on Prediction Time to Castration-Resistant Prostate Cancer: Indonesian Cohort Studies;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-04-07

2. Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review;Critical Reviews in Oncology/Hematology;2019-06

3. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer;The FASEB Journal;2017-07-13

4. Neuroendocrine differentiation in prostate cancer: Novel morphological insights and future therapeutic perspectives;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2014-12

5. Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies;Critical Reviews in Oncology/Hematology;2014-10